NASDAQ:AVAH Aveanna Healthcare (AVAH) Stock Price, News & Analysis $7.47 +0.43 (+6.11%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.36 -0.11 (-1.47%) As of 08/22/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Aveanna Healthcare Stock (NASDAQ:AVAH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aveanna Healthcare alerts:Sign Up Key Stats Today's Range$7.05▼$7.6950-Day Range$3.74▼$7.4752-Week Range$3.67▼$7.69Volume1.55 million shsAverage Volume1.74 million shsMarket Capitalization$1.56 billionP/E Ratio93.38Dividend YieldN/APrice Target$7.50Consensus RatingModerate Buy Company Overview Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia. Read More Aveanna Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreAVAH MarketRank™: Aveanna Healthcare scored higher than 38% of companies evaluated by MarketBeat, and ranked 702nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingAveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAveanna Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Aveanna Healthcare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aveanna Healthcare is 93.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Aveanna Healthcare is 93.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.10.Read more about Aveanna Healthcare's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.86% of the float of Aveanna Healthcare has been sold short.Short Interest Ratio / Days to CoverAveanna Healthcare has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aveanna Healthcare has recently decreased by 0.46%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAveanna Healthcare does not currently pay a dividend.Dividend GrowthAveanna Healthcare does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.86% of the float of Aveanna Healthcare has been sold short.Short Interest Ratio / Days to CoverAveanna Healthcare has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aveanna Healthcare has recently decreased by 0.46%, indicating that investor sentiment is improving. News and Social Media2.6 / 5News Sentiment0.65 News SentimentAveanna Healthcare has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Aveanna Healthcare this week, compared to 3 articles on an average week.Search Interest7 people have searched for AVAH on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,941,141.00 in company stock.Percentage Held by InsidersOnly 7.80% of the stock of Aveanna Healthcare is held by insiders.Percentage Held by Institutions87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aveanna Healthcare's insider trading history. Receive AVAH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address AVAH Stock News HeadlinesBarclays Upgrades Aveanna Healthcare Holdings (AVAH)August 21 at 5:37 AM | msn.comAveanna Healthcare (NASDAQ:AVAH) Raised to "Neutral" at UBS GroupAugust 21 at 3:57 AM | americanbankingnews.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.August 23 at 2:00 AM | The Oxford Club (Ad)Aveanna Healthcare (NASDAQ:AVAH) Sets New 1-Year High After Analyst UpgradeAugust 21 at 2:57 AM | americanbankingnews.comAveanna Healthcare (NASDAQ:AVAH) Raised to "Overweight" at BarclaysAugust 20 at 2:53 AM | americanbankingnews.comAveanna to Participate at the Deutsche Bank Healthcare SummitAugust 19, 2025 | globenewswire.comAveanna Healthcare Holdings' (NASDAQ:AVAH) Earnings Are Weaker Than They SeemAugust 15, 2025 | finance.yahoo.comUBS Group Increases Aveanna Healthcare (NASDAQ:AVAH) Price Target to $6.75August 14, 2025 | americanbankingnews.comSee More Headlines AVAH Stock Analysis - Frequently Asked Questions How have AVAH shares performed this year? Aveanna Healthcare's stock was trading at $4.57 at the beginning of the year. Since then, AVAH stock has increased by 63.5% and is now trading at $7.47. How were Aveanna Healthcare's earnings last quarter? Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) released its earnings results on Thursday, November, 7th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $509.02 million for the quarter, compared to the consensus estimate of $495.80 million. Aveanna Healthcare had a net margin of 0.85% and a negative trailing twelve-month return on equity of 54.56%. Read the conference call transcript. When did Aveanna Healthcare IPO? Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers. Who are Aveanna Healthcare's major shareholders? Aveanna Healthcare's top institutional investors include J.H. Whitney Equity Partners VII LLC (23.54%), Summit Partners L P (4.95%), King Street Capital Management L.P. (2.18%) and Geode Capital Management LLC (0.72%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Matthew Buckhalter, Patrick A Cunningham, David Afshar, Deborah Stewart and Victor F Ganzi. View institutional ownership trends. How do I buy shares of Aveanna Healthcare? Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aveanna Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings11/07/2024Today8/23/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:AVAH CIK1832332 Webwww.aveanna.com Phone770-441-1580FaxN/AEmployees33,500Year FoundedN/APrice Target and Rating Average Price Target for Aveanna Healthcare$7.50 High Price Target$9.50 Low Price Target$5.00 Potential Upside/Downside+0.4%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$0.08 Trailing P/E Ratio93.38 Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.93 million Net Margins0.85% Pretax Margin2.47% Return on Equity-54.56% Return on Assets3.17% Debt Debt-to-Equity RatioN/A Current Ratio1.09 Quick Ratio1.09 Sales & Book Value Annual Sales$2.02 billion Price / Sales0.77 Cash Flow$0.17 per share Price / Cash Flow42.94 Book Value($0.06) per share Price / Book-124.50Miscellaneous Outstanding Shares208,900,000Free Float192,602,000Market Cap$1.56 billion OptionableOptionable Beta1.95 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:AVAH) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aveanna Healthcare Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aveanna Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.